StandardMHRA
Statement of policy intent: relaunch of the Innovative Licensing and Access Pathway
A unique initiative which aims to accelerate the time to patient care for transformative medicines and medicine-device combinations.
First published: Nov 6, 2024Last updated: Nov 6, 2024Changes: 1
Latest change: First published.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.